112 related articles for article (PubMed ID: 23459109)
1. Differential surface properties of commercial crystalline telmisartan samples.
Laad P; Shete G; Modi SR; Bansal AK
Eur J Pharm Sci; 2013 May; 49(2):109-16. PubMed ID: 23459109
[TBL] [Abstract][Full Text] [Related]
2. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
[TBL] [Abstract][Full Text] [Related]
3. Dissolution properties and physical characterization of telmisartan-chitosan solid dispersions prepared by mechanochemical activation.
Zhong L; Zhu X; Luo X; Su W
AAPS PharmSciTech; 2013 Jun; 14(2):541-50. PubMed ID: 23430728
[TBL] [Abstract][Full Text] [Related]
4. Wettability and surface chemistry of crystalline and amorphous forms of a poorly water soluble drug.
Puri V; Dantuluri AK; Kumar M; Karar N; Bansal AK
Eur J Pharm Sci; 2010 May; 40(2):84-93. PubMed ID: 20230893
[TBL] [Abstract][Full Text] [Related]
5. Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release.
Tran PH; Tran HT; Lee BJ
J Control Release; 2008 Jul; 129(1):59-65. PubMed ID: 18501462
[TBL] [Abstract][Full Text] [Related]
6. Investigation of intrinsic dissolution behavior of different carbamazepine samples.
Sehić S; Betz G; Hadzidedić S; El-Arini SK; Leuenberger H
Int J Pharm; 2010 Feb; 386(1-2):77-90. PubMed ID: 19900519
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of telmisartan tablets prepared via the wet granulation method and pritor™ prepared using the spray-drying method.
Park J; Park HJ; Cho W; Cha KH; Yeon W; Kim MS; Kim JS; Hwang SJ
Arch Pharm Res; 2011 Mar; 34(3):463-8. PubMed ID: 21547679
[TBL] [Abstract][Full Text] [Related]
8. Amorphous ternary cyclodextrin nanocomposites of telmisartan for oral drug delivery: improved solubility and reduced pharmacokinetic variability.
Sangwai M; Vavia P
Int J Pharm; 2013 Sep; 453(2):423-32. PubMed ID: 22935741
[TBL] [Abstract][Full Text] [Related]
9. Effect of amorphization method on telmisartan solubility and the tableting process.
Lepek P; Sawicki W; Wlodarski K; Wojnarowska Z; Paluch M; Guzik L
Eur J Pharm Biopharm; 2013 Jan; 83(1):114-21. PubMed ID: 23085331
[TBL] [Abstract][Full Text] [Related]
10. Physical characteristics and chemical degradation of amorphous quinapril hydrochloride.
Guo Y; Byrn SR; Zografi G
J Pharm Sci; 2000 Jan; 89(1):128-43. PubMed ID: 10664545
[TBL] [Abstract][Full Text] [Related]
11. Wettability studies of morphine sulfate powders.
Prestidge CA; Tsatouhas G
Int J Pharm; 2000 Apr; 198(2):201-12. PubMed ID: 10767569
[TBL] [Abstract][Full Text] [Related]
12. Effect of crystal habits on the surface energy and cohesion of crystalline powders.
Shah UV; Olusanmi D; Narang AS; Hussain MA; Gamble JF; Tobyn MJ; Heng JY
Int J Pharm; 2014 Sep; 472(1-2):140-7. PubMed ID: 24928138
[TBL] [Abstract][Full Text] [Related]
13. Effect of crystal habit on the dissolution behaviour of simvastatin crystals and its relationship to crystallization solvent properties.
Bukovec P; Benkic P; Smrkolj M; Vrecer F
Pharmazie; 2016 May; 71(5):263-8. PubMed ID: 27348970
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization of three crystalline modifications of telmisartan by single crystal and high-resolution X-ray powder diffraction.
Dinnebier RE; Sieger P; Nar H; Shankland K; David WI
J Pharm Sci; 2000 Nov; 89(11):1465-79. PubMed ID: 11015691
[TBL] [Abstract][Full Text] [Related]
15. Blooming of Irganox 3114® antioxidant onto a medical grade elastomer. Impact of the recrystallization conditions on the antioxidant polymorphism, on the film wettability and on the antioxidant leachability.
Saunier J; Mazel V; Aymes-Chodur C; Yagoubi N
Int J Pharm; 2012 Nov; 437(1-2):89-99. PubMed ID: 22884835
[TBL] [Abstract][Full Text] [Related]
16. Unique "delta lock" structure of telmisartan is involved in its strongest binding affinity to angiotensin II type 1 receptor.
Ohno K; Amano Y; Kakuta H; Niimi T; Takakura S; Orita M; Miyata K; Sakashita H; Takeuchi M; Komuro I; Higaki J; Horiuchi M; Kim-Mitsuyama S; Mori Y; Morishita R; Yamagishi S
Biochem Biophys Res Commun; 2011 Jan; 404(1):434-7. PubMed ID: 21130741
[TBL] [Abstract][Full Text] [Related]
17. Solubilization of the poorly water soluble drug, telmisartan, using supercritical anti-solvent (SAS) process.
Park J; Cho W; Cha KH; Ahn J; Han K; Hwang SJ
Int J Pharm; 2013 Jan; 441(1-2):50-5. PubMed ID: 23262425
[TBL] [Abstract][Full Text] [Related]
18. Study of the recrystallization in coated pellets - effect of coating on API crystallinity.
Nikowitz K; Pintye-Hódi K; Regdon G
Eur J Pharm Sci; 2013 Feb; 48(3):563-71. PubMed ID: 23291037
[TBL] [Abstract][Full Text] [Related]
19. The characterization and comparison of spray-dried mannitol samples.
Hulse WL; Forbes RT; Bonner MC; Getrost M
Drug Dev Ind Pharm; 2009 Jun; 35(6):712-8. PubMed ID: 19514986
[TBL] [Abstract][Full Text] [Related]
20. Effects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartan.
Tran TT; Tran PH; Park JB; Lee BJ
Arch Pharm Res; 2012 Jul; 35(7):1223-30. PubMed ID: 22864745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
